$49.05 -0.36 (-0.73%)
2/10/2012 4:00 PM

United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 3 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Featured Broker Partners


Advertisement